Development on Nasal Spray That Protects Against Common Cold, Coronavirus
Research on a new drug that prepares the respiratory tract immune system against infection and is currently being developed for the coronavirus has also shown its efficacy against rhinovirus. Rhinovirus is a common respiratory infection that is responsible for aggravating chronic obstructive pulmonary disease and chronic respiratory diseases such as asthma. This respiratory virus is also the primary cause of the common cold. The researchers found that treatment with the drug INNA-X before getting infected by the rhinovirus suppressed harmful inflammation and significantly decreased viral load. Associate professor Nathan Bartlett of the Hunter Medical Research Institute and the University of…
